ReviewTranslational lung cancer research2019

Third-generation epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer.

Natalie M Andrews Wright et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.